Meiji Holdings Co Ltd (2269):企業の財務・戦略的SWOT分析

◆英語タイトル:Meiji Holdings Co Ltd (2269) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C7670
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:38
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:消費財
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Meiji Holdings Co Ltd (2269) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Meiji Holdings Co Ltd (Meiji Holdings) develops, produces and distributes food and pharmaceutical products that comprise dairy, confectionery, nutrition, healthcare and pharmaceutical businesses. Its product portfolio includes drinking milk, yogurt, cheese, ice cream, crackers and cookies, frozen food, chocolates and chocolate snacks, gummies, beauty supplements and over-the-counter (OTC) drugs. It also offers ethical pharmaceutical drugs, generic drugs, veterinary medicines, human vaccines and blood plasma products. The company markets and sells these products under various brands including Meiji, VAAM, SAVAS, SYCREST and MEIACT, for a few. Meiji Holding provides transportation and storage services. It manages and operates sales offices, R&D centers and production facilities in Asia-Pacific, Europe and North America regions. Meiji Holdings is headquartered in Tokyo, Japan.

Meiji Holdings Co Ltd Key Recent Developments

Sep 21,2018: Meiji Files Aricept Generic for Lewy Body Dementia to Win Full Indications
Sep 21,2018: Meiji Seika Pharma Commences Shipment of KM Biologics’ Flu Vaccine
Feb 07,2018: Meiji reports consolidated financial results for first nine months of fiscal year ending March 31, 2018

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
Meiji Holdings Co Ltd – Key Facts 5
Meiji Holdings Co Ltd – Key Employees 6
Meiji Holdings Co Ltd – Key Employee Biographies 7
Meiji Holdings Co Ltd – Major Products and Services 8
Meiji Holdings Co Ltd – History 10
Meiji Holdings Co Ltd – Company Statement 13
Meiji Holdings Co Ltd – Locations And Subsidiaries 14
Head Office 14
Other Locations & Subsidiaries 14
Section 2 – Company Analysis 15
Company Overview 15
Meiji Holdings Co Ltd – Business Description 16
Business Segment: Food 16
Overview 16
Performance 16
Key Stats 16
Business Segment: Pharmaceutical 17
Overview 17
Performance 17
Business Segment: Pharmaceuticals 17
Key Stats 17
Meiji Holdings Co Ltd – Corporate Strategy 18
Meiji Holdings Co Ltd – SWOT Analysis 20
SWOT Analysis – Overview 20
Meiji Holdings Co Ltd – Strengths 20
Meiji Holdings Co Ltd – Weaknesses 22
Meiji Holdings Co Ltd – Opportunities 23
Meiji Holdings Co Ltd – Threats 24
Meiji Holdings Co Ltd – Key Competitors 25
Section 3 – Company Financial Ratios 26
Financial Ratios – Capital Market Ratios 26
Financial Ratios – Annual Ratios 27
Performance Chart 30
Financial Performance 30
Financial Ratios – Interim Ratios 31
Financial Ratios – Ratio Charts 32
Meiji Holdings Co Ltd, Recent Deals Summary 33
Section 4 – Appendix 34
Methodology 34
Ratio Definitions 34
About GlobalData 38
Contact Us 38
Disclaimer 38

List of Tables
Meiji Holdings Co Ltd, Key Facts 5
Meiji Holdings Co Ltd, Key Employees 6
Meiji Holdings Co Ltd, Key Employee Biographies 7
Meiji Holdings Co Ltd, Major Products and Services 8
Meiji Holdings Co Ltd, History 10
Meiji Holdings Co Ltd, Other Locations 14
Meiji Holdings Co Ltd, Subsidiaries 14
Meiji Holdings Co Ltd, Key Competitors 25
Meiji Holdings Co Ltd, Ratios based on current share price 26
Meiji Holdings Co Ltd, Annual Ratios 27
Meiji Holdings Co Ltd, Annual Ratios (Cont...1) 28
Meiji Holdings Co Ltd, Annual Ratios (Cont...2) 29
Meiji Holdings Co Ltd, Interim Ratios 31
Meiji Holdings Co Ltd, Recent Deals Summary 33
Currency Codes 34
Capital Market Ratios 34
Equity Ratios 35
Profitability Ratios 35
Cost Ratios 36
Liquidity Ratios 36
Leverage Ratios 37
Efficiency Ratios 37

List of Figures
Meiji Holdings Co Ltd, Performance Chart (2014 - 2018) 30
Meiji Holdings Co Ltd, Ratio Charts 32

★海外企業調査レポート[Meiji Holdings Co Ltd (2269):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ProMIS Neurosciences Inc (PMN)-医療機器分野:企業M&A・提携分析
    Summary ProMIS Neurosciences Inc (ProMIS), formerly Amorfix Life Sciences Ltd. is a development stage biopharmaceutical company which focuses on the development of therapeutic antibodies and diagnostics for the treatment of misfolded protein diseases. The company uses ProMIS technology, which helps …
  • Ocean Rig UDW Inc (ORIG):石油・ガス:M&Aディール及び事業提携情報
    Summary Ocean Rig UDW Inc (Ocean Rig), formerly Primelead Shareholders Inc is an offshore drilling contractor that offers oilfield services. The company owns and operates 13 offshore ultra deepwater drilling units including ultra deepwater semi submersible drilling rigs, and ultra deepwater drillshi …
  • Grand Hotel Varna Resort & Spa:企業の戦略・SWOT・財務情報
    Grand Hotel Varna Resort & Spa - Strategy, SWOT and Corporate Finance Report Summary Grand Hotel Varna Resort & Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Oasis Petroleum Inc (OAS):石油・ガス:M&Aディール及び事業提携情報
    Summary Oasis Petroleum Inc. (Oasis Petroleum) is an independent exploration and production company. It focuses on the acquisition and development of unconventional oil and natural gas resources. The company operates in the Williston Basin in North Dakota and Montana and Permian Basin. The company f …
  • Vivus Inc (VVUS):企業の財務・戦略的SWOT分析
    Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Lam Research Corp (LRCX):企業の財務・戦略的SWOT分析
    Lam Research Corp (LRCX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Baker Botts LLP:企業の戦略的SWOT分析
    Baker Botts LLP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Bio Blast Pharma Ltd (ORPN):企業の財務・戦略的SWOT分析
    Summary Bio Blast Pharma Ltd (Bioblast Pharma) is a clinical stage biotechnology company that discovers, delivers, and develops clinical therapies for patients with rare and ultra-rare genetic diseases. The company discovers and develops pipeline products using platforms such as cabaletta, a mutant …
  • Wellcome Trust Sanger Institute:医療機器:M&Aディール及び事業提携情報
    Summary Wellcome Trust Sanger Institute (Sanger Institute) a subsidiary of Genome Research Ltd is a genomic discovery and research centre that carries out research and development in the areas of cellular and human genetics and infection genomics. It also provides postgraduate training on research a …
  • Apricus Biosciences Inc (APRI):製薬・医療:M&Aディール及び事業提携情報
    Summary Apricus Biosciences Inc (Apricus) develops and commercializes pharmaceutical products indicated for the treatment of various therapeutic classes including urology and rheumatology. Its product pipeline includes, Vitaros (alprostadil), a topical vasodilator cream in-licensed from Warner Chilc …
  • Kawasaki Kisen Kaisha, Ltd.:企業の戦略・SWOT・財務分析
    Kawasaki Kisen Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Kawasaki Kisen Kaisha, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Buongiorno SpA:企業の戦略的SWOT分析
    Buongiorno SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Bioxyne Ltd (BXN):製薬・医療:M&Aディール及び事業提携情報
    Summary Bioxyne Ltd (Bioxyne), is a biotechnology company that develops, manufactures, markets and commercializes healthcare products in the areas of immune health and immunotherapeutics. It manufactures consumer food supplements such as, ProTract and Progastrim, which are based on a proprietary pro …
  • Amgen Inc (AMGN)-製薬・医療分野:企業M&A・提携分析
    Summary Amgen Inc (Amgen) is a biotechnology company that discovers, develops, manufactures and markets innovative human therapeutics to improve the lives of patients suffering from serious diseases. It develops novel medicines in six focused therapeutic areas including cardiovascular disease, oncol …
  • Huawei Technologies Co Ltd:企業の戦略的SWOT分析
    Huawei Technologies Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Covis Pharma Sarl-製薬・医療分野:企業M&A・提携分析
    Summary Covis Pharma Sarl (Covis Pharma), a subsidiary of Concordia International Corp is a specialty pharmaceutical company that develops and markets drugs for the treatment of life-threatening conditions and chronic illnesses. The company develops products for central nervous system and rheumatic …
  • Pakistan Petroleum Ltd (PPL):企業の財務・戦略的SWOT分析
    Pakistan Petroleum Ltd (PPL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Ashok Leyland Limited:企業の戦略・SWOT・財務分析
    Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report Summary Ashok Leyland Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • B&M European Value Retail S.A.:企業の戦略・SWOT・財務情報
    B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report Summary B&M European Value Retail S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Tianjin Zhongxin Pharmaceutical Group Corp Ltd (600329):企業の財務・戦略的SWOT分析
    Summary Tianjin Zhongxin Pharmaceutical Group Corp Ltd (TZPG) carries out the manufacturing of traditional Chinese medicine, western medicine and health products. The company offers Chinese patent medicines, Chinese medicinal materials, chemical medicines, dietary supplements, pharmaceutical raw mat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆